Industry: Pharmaceuticals, Biotechnology
Intercytex is an emerging healthcare company developing cell therapy products for the woundcare and aesthetic medicine markets. It is using its proprietary expertise in cell therapy to develop products that harness the innate ability of human cells to regenerate and repair the body. Intercytex has four products in development: ICX-PRO, designed to stimulate active repair in chronic wounds in Phase III trials for VLUs and Phase II trials for DFUs; ICX-SKN, being developed as a durable and robust skin replacement, due to start Phase I trials later this year; ICX-RHY, a facial rejuvenation product which has completed a Phase I clinical trial and will enter Phase II trials by the end of this year; and ICX-TRC, a hair regeneration product which has recently entered Phase II clinical trials. ( www.intercytex.com )
Intercytex Limited
Innovation House Oaks Business Park Crewe Road
Manchester, M23 9QR
United Kingdom
Tel: +44 161 904 4500
Fax: +44 161 904 4510